This site is intended for Healthcare Professionals only.

Oxcarbazepine 300mg and 600 mg tablets to be out of stock until mid-July 2023

Date:

Share post:

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxcarbazepine (Trileptal) 300mg and 600mg tablets on Wednesday (14 June). 

It has notified that the Oxcarbazepine (Trileptal) 300mg tablets will be out of stock from late June 2023 until mid-July 2023 and Oxcarbazepine (Trileptal) 600mg tablets are out of stock until mid-July 2023.

However, generic oxcarbazepine 300mg and 600mg tablets remain available and will be able to support increased demand.

“Oxcarbazepine (Trileptal) 150mg tablets and generic oxcarbazepine 150mg tablets remain available but cannot support the increase in demand,” said DHSC. “Oxcarbazepine (Trileptal) 60mg/ml oral suspension remains available but cannot meet an increase in demand.”

DHSC has sent a copy of this medicine supply notification, including further information for pharmacy teams, to all pharmacy NHS email addresses.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Vaping may damage your fertility, study warns women

Concerningly, it also found that one in five British women vape while trying to get pregnant Women who...

Pharmacy Business Conference 2024 envisions the pharmacy of tomorrow

Pharmacy professionals address sector challenges, emphasising funding, data-driven arguments, and patient-centric care for tomorrow's healthcare The 8th Pharmacy Business...

Pharmacy Business Conference 2024: Many agree the future for community pharmacy is positive

Community pharmacy at this time is underpaid, stretched, uncertain, dying, chaotic, unappreciated, or overworked. Despite the challenges confronting...

India drug raids: 13 arrested, £22 million worth of mephedrone seized

The Gujarat Anti-Terrorist Squad (ATS) recovered 22.028 kilograms of mephedrone (in solid form) and 124 kilograms of liquid...